MediWound (MDWD) Income from Continuing Operations (2013 - 2025)
MediWound (MDWD) recorded quarterly Income from Continuing Operations of 7727000.0 in Q4 2025, down 19.39% quarter-over-quarter from 6472000.0 in Q3 2025, and down 27.03% on a YoY basis from 10588722.91 in Q4 2024.
MediWound (MDWD) Income from Continuing Operations (2013 - 2025) Analysis & Trends
MediWound's Income from Continuing Operations history runs 13 years deep, the most recent figure standing at 7727000.0 for Q4 2025.
- In Q4 2025, Income from Continuing Operations fell 27.03% year-over-year to 7727000.0; the TTM figure through Dec 2025 stood at 32661000.0 (down 54.34% YoY), while the FY2025 annual figure was 23541000.0, up 21.8% from the prior year.
- Income from Continuing Operations was 7727000.0 for Q4 2025 at MediWound, down from 6472000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 940000.0 in Q2 2023 to a low of 13242000.0 in Q2 2025.
- Historically, Income from Continuing Operations has averaged 4655450.0 across 5 years, with a median of 4170500.0 in 2021.
- The sharpest annual moves came in 2023 and 2024: Income from Continuing Operations jumped 121.63% in 2023, then sank 771.17% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 4152000.0 in 2021, then plunged by 76.47% to 7327000.0 in 2022, then jumped by 79.49% to 1503000.0 in 2023, then sank by 304.72% to 6083000.0 in 2024, then slipped by 27.03% to 7727000.0 in 2025.
- The last three Income from Continuing Operations figures came in at 7727000.0 (Q4 2025), 6472000.0 (Q3 2025), and 13242000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.80 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.40 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.48 Mn |
| 10 | MediWound | 3.70 Mn | 3.70 Mn | 278,000.00 | -7.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.73 Mn |
| Sep 30, 2025 | -6.47 Mn |
| Jun 30, 2025 | -13.24 Mn |
| Mar 31, 2025 | -5.22 Mn |
| Dec 31, 2024 | -6.08 Mn |
| Sep 30, 2024 | -5.06 Mn |
| Jun 30, 2024 | -6.31 Mn |
| Mar 31, 2024 | -3.71 Mn |
| Dec 31, 2023 | -1.50 Mn |
| Sep 30, 2023 | -2.10 Mn |
| Jun 30, 2023 | 940,000.00 |
| Mar 31, 2023 | -3.68 Mn |
| Dec 31, 2022 | -7.33 Mn |
| Sep 30, 2022 | -4.19 Mn |
| Jun 30, 2022 | -4.35 Mn |
| Mar 31, 2022 | -3.58 Mn |
| Dec 31, 2021 | -4.15 Mn |
| Sep 30, 2021 | -3.34 Mn |
| Jun 30, 2021 | -3.16 Mn |
| Mar 31, 2021 | -2.85 Mn |